- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tibet Aim Pharm Inc (002826)
Tibet Aim Pharm Inc stock price live, this page displays SZ 002826 stock exchange data. View the 002826 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tibet Aim Pharm Inc real time stock price chart below.
What Is the Tibet Aim Pharm Inc Stock Price Today?
The Tibet Aim Pharm Inc stock price today is 23.35.
What Is the Stock Symbol for Tibet Aim Pharm Inc?
The stock symbol for Tibet Aim Pharm Inc is ""002826.""
What Stock Exchange Does Tibet Aim Pharm Inc Trade On?
Tibet Aim Pharm Inc is listed and trades on the Shenzhen stock exchange.
Is Tibet Aim Pharm Inc a Good Stock to Buy?
Determining whether Tibet Aim Pharm Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 002826 quote. (ISIN: CNE100002C39)
What Is the Tibet Aim Pharm Inc Stock Price Today?
The Tibet Aim Pharm Inc stock price today is 23.35.
What Is the Stock Symbol for Tibet Aim Pharm Inc?
The stock symbol for Tibet Aim Pharm Inc is ""002826.""
What Stock Exchange Does Tibet Aim Pharm Inc Trade On?
Tibet Aim Pharm Inc is listed and trades on the Shenzhen stock exchange.
Is Tibet Aim Pharm Inc a Good Stock to Buy?
Determining whether Tibet Aim Pharm Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 002826 quote. (ISIN: CNE100002C39)
Shenzhen
Currency in CNY
23.35
-0.15(-0.64%)
Closed·
Fair Value
An estimate of a Tibet Aim Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.67
24.30
52 wk Range
7.53
25.60
002826 Scorecard
Full Analysis
Management has been aggressively buying back shares
002826 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Tibet Aim Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.6724.30
52 wk Range
7.5325.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
002826 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Tibet Aim Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Tibet Aim Pharm Inc Company Profile
Tibet AIM Pharm. Inc. engages in the research and development, manufacturing, and sale of medical products in China. The company’s products include Miglitol tablets for diabetes; Gualoupi injection for coronary disease; Oxytocin injection for gynecology and obstetrics; and NalMefene injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypnotic, opioid substance, serious infection, shock, fainting, and brain, as well as coma, spinal cord injury, cerebral infarction, hemorrhage, etc. It also provides Carbetocin injections for prevention of postpartum hemorrhage; Domperidone tablets for treatment of indigestion, abdominal bloating, belching, nausea, vomiting, and abdominal distension and pain; Montmorillonite powder for chronic diarrhea; Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotics, antiallergic, and digestive systems. Tibet AIM Pharm. Inc. was founded in 2003 and is headquartered in Beijing, China.
Compare 002826 to Peers and Sector
Metrics to compare | 002826 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002826PeersSector | |
|---|---|---|---|---|
P/E Ratio | 116.1x | 31.1x | −0.5x | |
PEG Ratio | 17.12 | −0.16 | 0.00 | |
Price/Book | 5.6x | 3.2x | 2.6x | |
Price / LTM Sales | 6.7x | 4.8x | 3.3x | |
Upside (Analyst Target) | - | 10.6% | 40.3% | |
Fair Value Upside | Unlock | 3.3% | 5.1% | Unlock |
Earnings
Latest Release
Apr 24, 2025
EPS / Forecast
0.10 / --
Revenue / Forecast
148.53M / --
FAQ
What Stock Exchange Does Tibet Aim Pharm Trade On?
Tibet Aim Pharm is listed and trades on the Shenzhen Stock Exchange stock exchange.
What Is the Stock Symbol for Tibet Aim Pharm?
The stock symbol for Tibet Aim Pharm is "002826."
What Is the Tibet Aim Pharm Market Cap?
As of today, Tibet Aim Pharm market cap is 4.28B.
What Is Tibet Aim Pharm's Earnings Per Share (TTM)?
The Tibet Aim Pharm EPS (TTM) is 0.20.
From a Technical Analysis Perspective, Is 002826 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Tibet Aim Pharm Stock Split?
Tibet Aim Pharm has split 0 times.
How Many Employees Does Tibet Aim Pharm Have?
Tibet Aim Pharm has 403 employees.
What is the current trading status of Tibet Aim Pharm (002826)?
As of 16 Aug 2025, Tibet Aim Pharm (002826) is trading at a price of 23.35, with a previous close of 23.50. The stock has fluctuated within a day range of 22.67 to 24.30, while its 52-week range spans from 7.53 to 25.60.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.